Rapiblyk 84381-0110
Generic: Landiolol
Product NDC
84381-0110- Manufacturer
- Aop Orphan Pharmaceuticals Gmbh
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 7, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA217202
Need to source Rapiblyk? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Landiolol Hydrochloride | 280 mg/1 |
Drug Class
Adrenergic beta1-Antagonists [MoA]beta-Adrenergic Blocker [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (84381-110-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE